Filter Results:
(611)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
recommendations in my mind to improve the pace of nuclear innovation. A clear direction for improvement would be to adopt a Food and Drug Administration-style drug development type regulatory model with... View Details
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Public Interest: Roche & Tamiflu Harvard Business School Case 609-061 The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu.... View Details
Keywords: Martha Lagace
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
process of testing drugs and bringing them to market. No matter how ingenious a business model may appear, however, all panelists agreed that the trust of patients remains paramount. Patient trust, then, could well emerge as the ultimate... View Details
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
problems that were posted? A: Innovations happen at the intersection of disciplines. People have talked about that a lot and I think we're providing some systematic evidence now with this study. Another example is that a pharmaceutical company got unusual toxicology... View Details
Keywords: by Martha Lagace
- 11 Oct 2006
- Research & Ideas
The Success of Reverse Leveraged Buyouts
business press and savvy business experts such Warren Buffett. It didn’t help when one of the most publicized RLBOs—Refco—collapsed in 2005 shortly after its initial public offering. And on September 21, a 70-million share offering for View Details
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074 This case presents the Myelin... View Details
Keywords: Martha Lagace
- 14 Apr 2021
- Research & Ideas
The High Cost of the Slow COVID Vaccine Rollout
the United States, the Federal Drug Administration this week advised states to pause the use of the Johnson & Johnson vaccine after six women developed a rare blood-clotting disorder, raising new concerns about total vaccine supply.... View Details
- 28 Apr 2009
- First Look
First Look: April 28, 2009
consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based... View Details
Keywords: Martha Lagace
- 26 Sep 2006
- First Look
First Look: September 26, 2006
the pandemic. Most have not been very successful. An examination of three strategies for distributing antiretroviral drugs (ARVs) to patients in three countries on three continents, Africa, Asia, and South America, suggests a customer... View Details
Keywords: Sean Silverthorne
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
including a 20-article investigative series in the New York Times that discovered similar cases at other hospitals. The US Food and Drug Administration (FDA) started investigations of the CT devices, dozens of patients joined in a... View Details
- 27 Sep 2011
- First Look
First Look: September 27
Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and testing. With health benefits... View Details
Keywords: Sean Silverthorne
- 19 Nov 2014
- HBS Case
Marketing Marijuana
something that hadn't been done in 81 years—make an illegal drug legal. “They do not need to buy it at a fancy store—they'll go to a back alley basement shop as long as the product delivers” Of course, the question remains: How will state... View Details
- 05 Jul 2004
- Research & Ideas
Radical Change, Entrepreneurial Opportunity
tightly coupled relationships with customers to engage in trials of different product concepts, producers and users can jointly learn about and make sense of the new technology. For instance, Surface Logix, a firm with highly sophisticated, flexible technology called... View Details
- 15 Dec 2014
- Research & Ideas
Deconstructing the Price Tag
expenses incurred. For example, R&D expenditures in the pharmaceutical industry involve more than just the cost of producing one particular drug. Many drugs may have to fail before one succeeds, and that one hit View Details
- 28 Jul 2009
- First Look
First Look: July 28
report, new CEO Hank McKinnell discusses Pfizer's performance goals and its acquisition of Pharmacia, which gave it control of the anti-arthritis drug Celebrex. In the 2005 report, McKinnell discusses his decision to keep Celebrex on the... View Details
Keywords: Martha Lagace
- 15 Jun 2016
- Research & Ideas
These VC Partners May Make Your Firm Less Innovative
developed by the Food and Drug Administration (FDA), they were able to tell which companies were competitors in the same patient application areas (such as cardiology, oncology, or urology) and product classes. Then, using commercial... View Details
- 25 Aug 2015
- First Look
First Look Tuesday
to examine the phenomena in the context of health. In particular, we examine how an individual's prior experiences and the experiences of those around them alter the operational decisions that the individual makes. We draw on an exogenous announcement of negative news... View Details
- 05 Nov 2007
- Research & Ideas
The Changing Face of American Innovation
on? Are they concentrated in a specific industry or business type? A: Inventors can file for patents in many technology fields, ranging from chemicals and drugs to computer software to agricultural machinery. Immigrant contributions are... View Details
- 20 May 2016
- Op-Ed
World Health Organization Lacks Leadership to Combat Pandemics
greater role in WHO governance and if there are guarantees of purchase contracts for new drugs and vaccines at sensible prices. Both seem unlikely, as the WHO's culture has always winced at cooperation with the private sector. WHO's track... View Details
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow treatment regimens for chronic... View Details
Keywords: by Regina E. Herzlinger